Camden Capital »

Regeneron Pharmaceuticals shares owned by Camden Capital

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Camden Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.6M 1.5k 1050.97
2024-06-30 $1.8M 1.7k 1050.78
2024-03-31 $1.2M 1.2k 962.17
2023-12-31 $970k 1.1k 878.48
2023-09-30 $548k 665 823.49
2023-06-30 $418k 582 718.56
2023-03-31 $255k 310 821.67